| Out in the green: biologically active metabolites produced by cyanobacteria. | |
| | |
MedLine Citation:
|
PMID: 21797171 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Dried cyanobacteria ('Spirulina') are sold as a nutraceutical for their high content of proteins, essential fatty acids and vitamins. Beyond spirulina, other genera of cyanobacteria produce interesting small molecules that could find use in nutraceutical or pharmaceutical applications. This account presents recent research efforts on antimalarial nostocarboline and the aerucyclamides, as well as on potent toxins such as cyanopeptolin 1020 and microcystins. Combinations of spectroscopic, computational, chemical and biological studies investigated the mechanism of action of these compounds. Their application potential with regard to nutraceuticals or pharmaceuticals is discussed. |
| | |
Authors:
|
Karl Gademann |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Chimia Volume: 65 ISSN: 0009-4293 ISO Abbreviation: Chimia (Aarau) Publication Date: 2011 |
Date Detail:
|
Created Date: 2011-07-29 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0373152 Medline TA: Chimia (Aarau) Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 416-9 Citation Subset: IM |
Affiliation:
|
University of Basel, Department of Chemistry, St. Johanns-Ring 19, CH-4056 Basel. karl.gademann@unibas.ch |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Bioreduction-mediated food-drug interactions: opportunities for oncology nutrition.
Next Document: Large-scale production of bioactive ingredients as supplements for healthy human and animal nutritio...